Table 1.
Significant effects of Rb9 (χ2 statistics) on different populations of human neutral (TNF), activated (LPS), or suppressed (IL-10 + TGF-β) dendritic cells (DCs)a.
mDC markers | Systems Rb9 and controls | Statistics of Rb9 effects | Stimuli |
---|---|---|---|
CD11c | LPS | C | |
HLA-DR | LPS + Rb9 | X2 p < 0.05 | *Neg |
TNF | C | ||
TNF + Rb9 | X2 NS | 0 | |
IL-10 + TGF-β | C | ||
IL-10/TGF-β + Rb9 | X2 p < 0.01 | **Pos | |
CD83 | LPS | C | |
HLA-DR | LPS + Rb9 | X2 NS | 0 |
TNF | C | ||
TNF + Rb9 | X2 NS | 0 | |
IL-10 + TGF-β | C | ||
IL-10/TGF-β + Rb9 | X2 p < 0.01 | **Pos | |
CD80 | LPS | C | |
CD86 | LPS + Rb9 | X2 NS | 0 |
TNF | C | ||
TNF + Rb9 | X2 NS | 0 | |
IL-10 + TGF-β | C | ||
IL-10/TGF-β + Rb9 | X2 p < 0.01 | **Pos |
Results obtained in a flow cytometer (see Supplementary Figure 4). C, control system; X2, Chi- squared statistics;
Neg, significant inhibitory effect;
Pos, significant activation; NS, not significant effect.